Literature DB >> 20727982

Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation.

Cele Abad-Zapatero1, Ognjen Perišić, John Wass, A Patrícia Bento, John Overington, Bissan Al-Lazikani, Michael E Johnson.   

Abstract

We propose a numerical framework that permits an effective atlas-like representation of chemico-biological space based on a series of Cartesian planes mapping the ligands with the corresponding targets connected by an affinity parameter (K(i) or related). The numerical framework is derived from the concept of ligand efficiency indices, which provide a natural coordinate system combining the potency toward the target (biological space) with the physicochemical properties of the ligand (chemical space). This framework facilitates navigation in the multidimensional drug discovery space using map-like representations based on pairs of combined variables related to the efficiency of the ligands per Dalton (molecular weight or number of non-hydrogen atoms) and per unit of polar surface area (or number of polar atoms).
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727982     DOI: 10.1016/j.drudis.2010.08.004

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  24 in total

1.  Mappability of drug-like space: towards a polypharmacologically competent map of drug-relevant compounds.

Authors:  Pavel Sidorov; Helena Gaspar; Gilles Marcou; Alexandre Varnek; Dragos Horvath
Journal:  J Comput Aided Mol Des       Date:  2015-11-12       Impact factor: 3.686

2.  Protein pocket and ligand shape comparison and its application in virtual screening.

Authors:  Matthias Wirth; Andrea Volkamer; Vincent Zoete; Friedrich Rippmann; Olivier Michielin; Matthias Rarey; Wolfgang H B Sauer
Journal:  J Comput Aided Mol Des       Date:  2013-06-27       Impact factor: 3.686

3.  AtlasCBS: a web server to map and explore chemico-biological space.

Authors:  Alvaro Cortés-Cabrera; Antonio Morreale; Federico Gago; Celerino Abad-Zapatero
Journal:  J Comput Aided Mol Des       Date:  2012-07-14       Impact factor: 3.686

4.  Ligand efficiency metrics considered harmful.

Authors:  Peter W Kenny; Andrei Leitão; Carlos A Montanari
Journal:  J Comput Aided Mol Des       Date:  2014-06-05       Impact factor: 3.686

5.  Biomolecular chemistry of isopropyl fibrates.

Authors:  Ganesaratnam K Balendiran; Niharika Rath; Amanda Kotheimer; Chad Miller; Matthias Zeller; Nigam P Rath
Journal:  J Pharm Sci       Date:  2012-01-13       Impact factor: 3.534

6.  Biophysical limits of protein-ligand binding.

Authors:  Richard D Smith; Alaina L Engdahl; James B Dunbar; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2012-07-18       Impact factor: 4.956

Review 7.  Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis.

Authors:  Tian Zhu; Shuyi Cao; Pin-Chih Su; Ram Patel; Darshan Shah; Heta B Chokshi; Richard Szukala; Michael E Johnson; Kirk E Hevener
Journal:  J Med Chem       Date:  2013-06-07       Impact factor: 7.446

8.  Coumarin-Chalcone Hybrids as Inhibitors of MAO-B: Biological Activity and In Silico Studies.

Authors:  Guillermo Moya-Alvarado; Osvaldo Yañez; Nicole Morales; Angélica González-González; Carlos Areche; Marco Tulio Núñez; Angélica Fierro; Olimpo García-Beltrán
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

9.  Mycobacterial dihydrofolate reductase inhibitors identified using chemogenomic methods and in vitro validation.

Authors:  Grace Mugumbate; Katherine A Abrahams; Jonathan A G Cox; George Papadatos; Gerard van Westen; Joël Lelièvre; Szymon T Calus; Nicholas J Loman; Lluis Ballell; David Barros; John P Overington; Gurdyal S Besra
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

10.  Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Front Pharmacol       Date:  2015-05-13       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.